Počet záznamů: 1  

Administration of anti-CD25 mAb leads to impaired alpha-galactosylceramide-mediated induction of IFN-gamma production in a murine model

  1. 1.
    SYSNO ASEP0395907
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevAdministration of anti-CD25 mAb leads to impaired alpha-galactosylceramide-mediated induction of IFN-gamma production in a murine model
    Tvůrce(i) Rosalia, Rodney Alexander (UMG-J)
    Štěpánek, Ivan (UMG-J) RID
    Polláková, Veronika (UMG-J)
    Šímová, Jana (UMG-J) RID
    Bieblová, Jana (UMG-J)
    Indrová, Marie (UMG-J) RID
    Moravcová, Simona (UMG-J) RID
    Přibylová, Hana (UMG-J)
    Bontkes, H. (NL)
    Bubeník, Jan (UMG-J)
    Sparwasser, T. (DE)
    Reiniš, Milan (UMG-J) RID
    Zdroj.dok.Immunobiology. - : Elsevier - ISSN 0171-2985
    Roč. 218, č. 6 (2013), s. 851-859
    Poč.str.9 s.
    Jazyk dok.eng - angličtina
    Země vyd.DE - Německo
    Klíč. slovacancer immunotherapy ; DEREG mice ; interferon γ ; natural killer T cells ; PC61 monoclonal antibody ; T regulatory cells
    Vědní obor RIVEB - Genetika a molekulární biologie
    CEPGA301/07/1410 GA ČR - Grantová agentura ČR
    GAP301/10/2174 GA ČR - Grantová agentura ČR
    Institucionální podporaUMG-J - RVO:68378050
    CEZAV0Z50520514 - UMG-J (2005-2011)
    UT WOS000319486200003
    DOI10.1016/j.imbio.2012.10.012
    AnotaceCD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions. Depletion or inactivation of Tregs using specific anti-CD25 antibodies in combination with immunostimulation is an attractive modality especially in anti-tumour immunotherapy. However, CD25 is not expressed exclusively on Tregs but also on subpopulations of activated lymphocytes. Therefore, the modulatory effects of the specific anti-CD25 antibodies can also be partially attributed to their interactions with the effector cells. Here, the effector functions of iNKT cells were analysed in combination with anti-CD25 mAb PC61. Upon PC61 administration, alpha-galactosylceramide (alpha-GalCer)-mediated activation of iNKT cells resulted in decreased IFN-gamma but not IL-4 production. In order to determine whether mutual interactions between Tregs and iNKT cells take place, we compared IFN gamma production after alpha-GalCer administration in anti-CD25-treated and "depletion of regulatory T cell" (DEREG) mice. Since no profound effects on IFN gamma induction were observed in DEREG mice, deficient in FoxP3(+) Tregs, our results indicate that the anti-CD25 antibody acts directly on CD25(+) effector cells. In vivo experiments demonstrated that although both alpha-GalCer and PC61 administration inhibited TC-1 tumour growth in mice, no additive/synergic effects were observed when these substances were used in combination therapy. (C) 2012 Elsevier GmbH. All rights reserved.
    PracovištěÚstav molekulární genetiky
    KontaktNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Rok sběru2014
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.